Información de Boston Scientific Corp, dividendo de Boston Scientific Corp, actividades de los accionistas y más

Información de Boston Scientific Corp Compañía

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Información de la empresa

Código de la empresaBSX

Nombre de la empresaBoston Scientific Corp

Fecha de salida a bolsaMay 19, 1992

Fundada en1979

Director ejecutivoMr. Michael F. (Mike) Mahoney

Número de empleados53000

Tipo de títulosOrdinary Share

Fin del año fiscalMay 19

Dirección300 Boston Scientific Way

CiudadMARLBOROUGH

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal01752-1234

Teléfono15086834000

Sitio Webhttps://www.bostonscientific.com/en-US/Home.html

Código de la empresaBSX

Fecha de salida a bolsaMay 19, 1992

Fundada en1979

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionados

Cambio

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Mr. Yoshiaki Fujimori

Independent Director

2.90K

--

Ms. Miriam O' Sullivan

Chief Human Resource Officer, Senior Vice President

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Mr. Scott Olson

Senior Vice President, President - Cardiac Rhythm Management and Diagnostics

--

Nombre

Nombre/Posición

Posición

Accionados

Cambio

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Desglose de ingresos

Divisa: USDHora de actualización: mié., 2 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

10.21B

60.97%

EMEA (Europe, Middle East and Africa)

3.23B

19.28%

Asia Pacific

2.69B

16.04%

Latin America and Canada

624.00M

3.73%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

Accionista

Hora de actualización: vie., 21 de feb

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

Tipo

Accionista

Proporción

Investment Advisor

43.30%

Investment Advisor/Hedge Fund

37.30%

Hedge Fund

3.29%

Pension Fund

2.97%

Research Firm

2.45%

Bank and Trust

1.64%

Sovereign Wealth Fund

1.47%

Private Equity

0.21%

Insurance Company

0.21%

Other

7.16%

Participación institucional

Hora de actualización: dom., 19 de ene

Periodo de informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

2535

1.38B

93.49%

+4.22M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

2022Q4

1993

1.36B

94.66%

-54.91M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

132.25M

8.94%

+1.62M

+1.24%

Dec 31, 2024

Fidelity Management & Research Company LLC

121.20M

8.19%

-2.05M

-1.66%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

76.72M

5.19%

+7.50M

+10.84%

Dec 31, 2024

State Street Global Advisors (US)

63.96M

4.32%

+1.12M

+1.78%

Dec 31, 2024

PRIMECAP Management Company

36.93M

2.5%

-896.83K

-2.37%

Dec 31, 2024

Wellington Management Company, LLP

36.17M

2.45%

+3.34M

+10.19%

Dec 31, 2024

Geode Capital Management, L.L.C.

30.63M

2.07%

+1.04M

+3.52%

Dec 31, 2024

Capital World Investors

27.90M

1.89%

+6.22M

+28.67%

Dec 31, 2024

The Bollard Group, LLC

20.73M

1.4%

-510.32K

-2.40%

Dec 31, 2024

BlackRock Investment Management (UK) Ltd.

20.37M

1.38%

+757.90K

+3.86%

Dec 31, 2024

ETF relacionados

Hora de actualización: mié., 2 de abr

Nombre

Proporción

iShares U.S. Medical Devices ETF

12.01%

Goldman Sachs Future Health Care Equity ETF

8.56%

NYLI Healthy Hearts ETF

5.62%

iShares Health Innovation Active ETF

5.12%

JPMorgan Healthcare Leaders ETF

4.25%

Global X Aging Population ETF

4.17%

Hennessy Stance ESG ETF

3.4%

FT Raymond James Multicap Growth Equity ETF

2.84%

Tema Cardiovascular and Metabolic ETF

2.83%

Health Care Select Sector SPDR Fund

2.82%

iShares U.S. Medical Devices ETF

Proporción12.01%

Goldman Sachs Future Health Care Equity ETF

Proporción8.56%

NYLI Healthy Hearts ETF

Proporción5.62%

iShares Health Innovation Active ETF

Proporción5.12%

JPMorgan Healthcare Leaders ETF

Proporción4.25%

Global X Aging Population ETF

Proporción4.17%

Hennessy Stance ESG ETF

Proporción3.4%

FT Raymond James Multicap Growth Equity ETF

Proporción2.84%

Tema Cardiovascular and Metabolic ETF

Proporción2.83%

Health Care Select Sector SPDR Fund

Proporción2.82%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

No datos encontrados

División de acciones

Fecha

Tipo

Relación

No datos encontrados

Fecha

Tipo

Relación

No datos encontrados

Boston Scientific Corp

89.700USD

Boston Scientific Corp

89.700

Descripción general

Compañía